Jump to section
EQL's mission is to makes things to help people heal better and take control of their healthcare needs.
EQL believes that it's very difficult to manage a health condition: from finding the right doctor to keeping track of the symptoms, there are many steps that must be followed by patients in order to recover. The company aims to facilitate this process by creating Phio - an AI-driven chatbot that helps patients recover faster without any human intervention.
EQL stands out through the innovation surrounding its products. Phio Access and Phio Engage are two tools that use AI and machine learning to understand each patient's condition and empower them on their MSK healthcare journey. The tools help patients in various ways, such as recommending exercise programs tailored to their condition, allowing them to track their recovery progress, and providing them with real-time conversations with AI specially designed to adapt to 3k+ scenarios.
EQL's products are available on any device and in almost every language. What's more, the proprietary technology behind the tools is clinically robust and is developed with industry leaders.

Kirsty
Company Specialist at Welcome to the Jungle
Jason Ward
(Co-Founder & CEO)Previously Head of Corporate Development at Square Health, Co-Founder & CEO at Prive Health and was an Energy Options Broker at Enterprise Commodity Services Limited.
Peter Grinbergs
(Co-Founder & Chief Medical Officer)Was a Chief Medical Officer at Bodycare Clinics, a Business Analyst at Square Health and was the CEO at Physio 1st.
Samantha Medcraft
(Co-Founder & COO)Previously Operations Manager at Square Health and a Department Manager at Argent Rehabilitation.